Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Baulard

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
European Journal of Medicinal Chemistry|September 30, 2018
Efficient analoging around ethionamide to explore thioamides bioactivation pathways triggered by boosters in Mycobacterium tuberculosisMarion Prieri, Rosangela Frita, Nicolas Probst, et al.
International Journal of Pharmaceutics|May 20, 2017
Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugsGiuseppina Salzano, Jitendra Wankar, Stefano Ottani, et al.
Journal of Lipid Research|April 3, 2004
Identification of a novel class of omega,E,E-farnesyl diphosphate synthase from Mycobacterium tuberculosisRakesh K Dhiman, Mark C Schulbach, Sebabrata Mahapatra, et al.
Organic & Biomolecular Chemistry|January 26, 2016
A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boostersPetar O Nikiforov, Sachin Surade, Michal Blaszczyk, et al.
Organic & Biomolecular Chemistry|November 29, 2017
New active leads for tuberculosis booster drugs by structure-based drug discoveryNatalie J Tatum, John W Liebeschuetz, Jason C Cole, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1999
Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesisB Phetsuksiri, A R Baulard, A M Cooper, et al.
Biochemical and Biophysical Research Communications|April 19, 2017
Structural analysis of the interaction between spiroisoxazoline SMARt-420 and the Mycobacterium tuberculosis repressor EthR2Alexandre Wohlkönig, Han Remaut, Martin Moune, et al.
The Journal of Biological Chemistry|June 28, 2000
Activation of the pro-drug ethionamide is regulated in mycobacteriaA R Baulard, J C Betts, J Engohang-Ndong, et al.
Analytical Biochemistry|February 25, 2014
Unconventional surface plasmon resonance signals reveal quantitative inhibition of transcriptional repressor EthR by synthetic ligandsCéline Crauste, Nicolas Willand, Baptiste Villemagne, et al.
The Biochemical Journal|April 5, 2002
Ppm1, a novel polyprenol monophosphomannose synthase from Mycobacterium tuberculosisSudagar S Gurcha, Alain R Baulard, Laurent Kremer, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
European Journal of Medicinal Chemistry|September 30, 2018
Efficient analoging around ethionamide to explore thioamides bioactivation pathways triggered by boosters in Mycobacterium tuberculosisMarion Prieri, Rosangela Frita, Nicolas Probst, et al.
International Journal of Pharmaceutics|May 20, 2017
Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugsGiuseppina Salzano, Jitendra Wankar, Stefano Ottani, et al.
Journal of Lipid Research|April 3, 2004
Identification of a novel class of omega,E,E-farnesyl diphosphate synthase from Mycobacterium tuberculosisRakesh K Dhiman, Mark C Schulbach, Sebabrata Mahapatra, et al.
Organic & Biomolecular Chemistry|January 26, 2016
A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boostersPetar O Nikiforov, Sachin Surade, Michal Blaszczyk, et al.
Organic & Biomolecular Chemistry|November 29, 2017
New active leads for tuberculosis booster drugs by structure-based drug discoveryNatalie J Tatum, John W Liebeschuetz, Jason C Cole, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1999
Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesisB Phetsuksiri, A R Baulard, A M Cooper, et al.
Biochemical and Biophysical Research Communications|April 19, 2017
Structural analysis of the interaction between spiroisoxazoline SMARt-420 and the Mycobacterium tuberculosis repressor EthR2Alexandre Wohlkönig, Han Remaut, Martin Moune, et al.
The Journal of Biological Chemistry|June 28, 2000
Activation of the pro-drug ethionamide is regulated in mycobacteriaA R Baulard, J C Betts, J Engohang-Ndong, et al.
Analytical Biochemistry|February 25, 2014
Unconventional surface plasmon resonance signals reveal quantitative inhibition of transcriptional repressor EthR by synthetic ligandsCéline Crauste, Nicolas Willand, Baptiste Villemagne, et al.
The Biochemical Journal|April 5, 2002
Ppm1, a novel polyprenol monophosphomannose synthase from Mycobacterium tuberculosisSudagar S Gurcha, Alain R Baulard, Laurent Kremer, et al.
Pageof 6